Get the Stockscreener App
0.46
65.67%
-0.88
Marpai Inc stock is traded at $0.46, with a volume of 19,531.
It is down -65.67% in the last 24 hours and down -65.67% over the past month.
See More
Previous Close:
$1.34
Open:
$0.44
24h Volume:
19,531
Relative Volume:
65.26
Market Cap:
$N/A
Revenue:
$20.70M
Net Income/Loss:
$-12.09M
P/E Ratio:
-0.5938
EPS:
-0.7747
Net Cash Flow:
$-7.60M
1W Performance:
-65.67%
1M Performance:
-65.67%
6M Performance:
-65.67%
1Y Performance:
+3.84%
1-Day Range:
$0.416
$0.47
1-Week Range:
$0.416
$0.47
52-Week Range:
$0.416
$1.3402
Marpai Inc Stock (MRAI) Company Profile
Compare MRAI vs UNH, CVS, CI, ELV, HUM
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MRAI
Marpai Inc
|
0.46 | 0 | 20.70M | -12.09M | -7.60M | -0.7747 |
UNH
Unitedhealth Group Inc
|
275.59 | 250.15B | 447.57B | 12.81B | 16.08B | 13.19 |
CVS
Cvs Health Corp
|
71.48 | 90.94B | 402.11B | 1.73B | 7.81B | 1.3835 |
CI
Cigna Group
|
262.84 | 69.30B | 274.88B | 6.29B | 8.39B | 22.19 |
ELV
Elevance Health Inc
|
291.48 | 64.33B | 199.13B | 5.66B | 3.17B | 25.11 |
HUM
Humana Inc
|
169.90 | 20.40B | 129.66B | 1.20B | 375.00M | 9.8083 |
Marpai Inc Stock (MRAI) Latest News
Marpai (NASDAQ:MRAI) Stock Price Down 3.9% – Here’s Why - Defense World
Marpai Secures CEO Loan to Bolster Near-Term Liquidity - The Globe and Mail
Marpai enters $250,000 loan agreement with CEO Damien Lamendola - Investing.com India
Marpai, Inc. Files Form 8-K Announcing Promissory Note Dated March 9, 2026 - Minichart
Marpai Raises $250,000 Via 12% Promissory Note From CEO, Maturing May 10, 2026 - TradingView
CEO lends $250K to Marpai (OTCQX: MRAI) in short-term note - Stock Titan
Marpai enters $250,000 loan agreement with CEO Damien Lamendola By Investing.com - Investing.com UK
Marpai, Inc. Enters Marketing Agreement To Expand MarpaiRx National Distribution Channel - marketscreener.com
New deal gives MarpaiRx a shot at 1.5 million employees' pharmacy benefits - Stock Titan
Marpai, Inc. announced that it has received $0.25 million in funding - marketscreener.com
Intelligent Fanatics, Ian Cassel report 4.4% stake in Marpai (MRAI) - Stock Titan
MRAI SEC FilingsMarpai Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Marpai (NASDAQ:MRAI) Shares Up 15.2% – Time to Buy? - Defense World
MRAI Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Marpai, Inc. Secures Major Strategic Wins for MarpaiRx, Adding Over 19,000 Lives and Accelerating High-Growth Platform Expansion - ChartMill
Marpai Secures Key Clients to Accelerate Growth - Intellectia AI
Marpai Secures Insider Promissory Note for Working Capital - TipRanks
Marpai Signs Promissory Note With Damien Lamendola - TradingView
Marpai’s Strategic Moves Under Investor Scrutiny - AD HOC NEWS
Marpai, Inc. announced that it has received $0.41 million in funding - marketscreener.com
Marpai hires Mimi Davis as president of MarpaiRx to drive growth - Investing.com Australia
MARPAI, INC. HIRES PHARMACY EXECUTIVE MIMI DAVIS AS PRESIDENT OF MARPAIRX TO DRIVE STRATEGIC GROWTH - PR Newswire
Marpai consolidates leadership as CEO Damien Lamendola becomes President - The Globe and Mail
Marpai, Inc. Announces President Changes, Effective January 30, 2026 - marketscreener.com
MARPAI ANNOUNCES 2026 MOMENTUM and KEY PARTNERSHIP EXPANSION - marketscreener.com
Marpai, Inc. (NASDAQ: MRAI) gets 5.6% ownership filing from IFCM fund - Stock Titan
Marpai Announces New Equity Financing and Warrant Agreement - TipRanks
Marpai Signs Securities Purchase Agreement With Certain Investors - TradingView — Track All Markets
Marpai (OTCQX: MRAI) sells shares and warrants in $350,000 private deal - Stock Titan
Marpai, Inc. announced that it has received $0.35 million in funding - marketscreener.com
Marpai, Inc. Earnings Call Highlights Mixed Sentiment - MSN
Marpai reports strong 2026 sales and renews Aetna network agreement - Investing.com
Marpai reports strong 2026 sales and renews Aetna network agreement By Investing.com - Investing.com UK
MARPAI ANNOUNCES 2026 MOMENTUM AND KEY PARTNERSHIP EXPANSION - PR Newswire
Marpai (OTCQX: MRAI) renews Aetna ASA pact, adds Faircost Optimizer tool - Stock Titan
Marpai (NASDAQ:MRAI) Trading 11.4% Higher – Should You Buy? - Defense World
Marpai, Inc. (OTC:MRAI) Q3 2025 Earnings Call Transcript - Insider Monkey
Marpai, Inc. Reports Strong Q3 2025 Results - TipRanks
Earnings call transcript: Marpai Q3 2025 sees EPS miss, stock drops 20% - Investing.com India
Earnings call transcript: Marpai Q3 2025 sees EPS miss, stock drops 20% By Investing.com - Investing.com South Africa
Marpai reduces debt by $3 million in new agreement - MSN
MARPAI REPORTS THIRD QUARTER 2025 FINANCIAL RESULTS - The AI Journal
Marpai, Inc. SEC 10-Q Report - TradingView
[8-K] Marpai, Inc. Reports Material Event | MRAI SEC FilingForm 8-K - Stock Titan
Marpai announces $4 million private placement of common stock and warrants - Investing.com Australia
Marpai director Pons buys $50,000 in MRAI stock By Investing.com - Investing.com Nigeria
Marpai director Eitan Yaron buys $100,000 in MRAI stock By Investing.com - Investing.com Canada
Marpai director Eitan Yaron buys $100,000 in MRAI stock - Investing.com India
Marpai Signs Material Definitive Agreement - TipRanks
Marpai Inc Stock (MRAI) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.28%
2.07%
Cap:
|
Volume (24h):